You are here: Industry Insights > Catalent

News List

Catalent Appoints SVP, Chief HR Officer contractpharma
July 19, 2019
Ricardo Pravda brings more than 25 years of global experience across multiple HR disciplines.
Catalent, AveXis Enter Long-term Strategic Mfg. Pact contractpharma
July 17, 2019
AveXis will have dedicated manufacturing space at Paragon’s new commercial manufacturing center near Baltimore-Washington Int’l Airport.
Catalent Breaks Ground in Indiana contractpharma
July 16, 2019
$112 million drug product manufacturing facility will increase fill/finish capacity by 79,000 sq. ft.
Catalent Expands Global Spray Drying Ops contractpharma
July 10, 2019
Agreement with Sanofi Active Ingredient Solutions provides access to spray drying manufacturing services at Sanofi’s Haverhill, UK facility.
Catalent snaps up Novavax production sites and 100 employees in $18M deal fiercepharma
July 04, 2019
Another deal has been struck in the rapidly evolving market for gene therapy manufacturing. Just two months after Catalent jumped big time into the gene therapy realm, it is adding a couple of small vaccine production sites and a 100 employees to its oper
Thermo Fisher and Catalent to manufacture gene therapies being developed by Amicus fiercepharma
July 04, 2019
Amicus Therapeutics has already forked over $100 million for 10 gene therapies. It is building a new R&D operation to advance them. But when it comes to manufacturing, it is turning to CDMOs.
Amicus, Catalent Biologics Enter Gene Therapy Mfg. Pact contractpharma
July 03, 2019
Will support clinical and commercial supply needs for Pompe and other Lysosomal Disease Gene Therapy Programs.
Catalent to Purchase BMS Mfg. Facility in Anagni, Italy contractpharma
June 20, 2019
Catalent will continue to manufacture BMS products while offering access to sterile biologics fill/finish and oral solids manufacturing and packaging platforms.
Catalent Biologics, IVERIC bio Ink Mfg. Pact contractpharma
June 18, 2019
Paragon Gene Therapy, part of Catalent Biologics, will provide materials for preclinical and Phase 1/2 trials for IVERIC’s gene therapy product candidates.
Catalent Launches OneBio Suite contractpharma
May 29, 2019
Aims to address the challenges facing biologic development companies that are looking to accelerate programs to clinic or market.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 13 Next page